SCHEMBL17253341

SCHEMBL17253341

CC(=O)OCc1ccc(/N=N/c2ccc(C(C)=O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
MAPT P10636 3/20 0.56
RAB9A P51151 3/20 0.56
MAPK1 P28482 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
STAT3 P40763 1/20 0.56
STAT1 P42224 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 2/20 0.51
CYP1A1 P04798 1/20 0.50
CYP1B1 Q16678 1/20 0.50
KMT2A Q03164 2/20 0.48
MAOB P27338 6/20 0.47
MAOA P21397 1/20 0.46
NOS3 P29474 2/20 0.44
NOS1 P29475 2/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7110777 0.89 ALDH1A1 (0.64) MAPTRAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL132773 0.80 ALDH1A1 (0.78) MAPTMAPK1TDP1ALDH1A1KDM4E
SCHEMBL14336603 0.80 MAPT (0.83) NPC1MAPTRAB9AMAPK1SMN1; SMN2
SCHEMBL29042753 0.80 MAPT (0.83) NPC1MAPTRAB9AMAPK1SMN1; SMN2
SCHEMBL18806562 0.80 MAPT (0.83) NPC1MAPTRAB9AMAPK1SMN1; SMN2
SCHEMBL24212738 0.79 MAOB (0.48) SMN1; SMN2TDP1ALDH1A1KMT2AMAOB
SCHEMBL24212684 0.79 NPC1 (0.48) NPC1MAPTRAB9AMAPK1SMN1; SMN2
SCHEMBL12879091 0.79 ALDH1A1 (0.60) NPC1MAPTRAB9AMAPK1SMN1; SMN2
SCHEMBL25659210 0.77 ALDH1A1 (0.58) NPC1MAPTRAB9AMAPK1SMN1; SMN2
SCHEMBL100476 0.77 ALDH1A1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022012693-A1 CODRUG THAT DISINTEGRATES IN INTESTINE, PREPARATION THEREFOR, AND USE THEREOF 轶诺(浙江)药业有限公司 2022-01-20 WO disclosed
US-20170073452-A1 POLYGLYOXYLATES, MANUFACTURE AND USE THEREOF THE UNIVERSITY OF WESTERN ONTARIO (CA) 2017-03-16 US disclosed
US-20170073452-A1 POLYGLYOXYLATES, MANUFACTURE AND USE THEREOF THE UNIVERSITY OF WESTERN ONTARIO (CA) 2017-03-16 US disclosed
WO-2015168809-A1 POLYGLYOXYLATES, MANUFACTURE AND USE THEREOF THE UNIVERSITY OF WESTERN ONTARIO (CA) 2015-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170073452-A1 POLYGLYOXYLATES, MANUFACTURE AND USE THEREOF IDUA, IDE, PUF60 NPC1 4482/4885MAPT 302/4885RAB9A 4177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.